Question 1

What is the catalog number for EMD-503982?

Accepted Answer

The catalog number for EMD-503982 is M34238.

Question 2

What sizes are available for EMD-503982?

Accepted Answer

EMD-503982 is available in the following size(s): 1 g, 500 mg, 200 mg, 5 mg, 10 mg, 25 mg, 50 mg.

Question 3

How many pack sizes does EMD-503982 come in?

Accepted Answer

EMD-503982 is available in 7 different pack sizes.

Question 4

Is EMD-503982 in stock?

Accepted Answer

EMD-503982 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is EMD-503982 used for?

Accepted Answer

EMD-503982 is a potential Factor Xa and Factor VIIa inhibitor with potential anticancer and antitumor activity for the study of thromboembolic and neurological disorders.

Question 6

Do you ship this product with dry ice?

Accepted Answer

Some products, including certain cell lines and biologics, require dry ice for transportation, which carries an additional fee shown clearly in your quotation. Dry ice delivery isn’t always possible to every destination due to transit time or local restrictions, so we check feasibility in advance and you must store the goods at the correct temperature the moment they arrive.

Question 7

Is this product species cross-reactive?

Accepted Answer

Cross-reactivity data, based on available testing, is listed under the reactivity section of the datasheet. Contact us if you need reactivity confirmed for a species not listed.

Question 8

Is there an additional fee for hazardous or dry ice shipping of this product?

Accepted Answer

Yes, if this product requires dry ice or is classed as hazardous for transport, the additional fee will be explicitly shown in your quotation before you confirm the order, so there are no surprise charges later.

EMD-503982

Product Specifications

CAS Number

Stability

Purity

Weight

Molecular Formula

Notes

Receptor

Available Sizes

Frequently Asked Questions

Explore Other Products

Ulipristal

Research Grade Sasanlimab

Research Grade Sasanlimab

Research Grade Sasanlimab

Synapsin I - Synaptic Marker Antibody [G18B13]

SLC16A1 Recombinant Protein (Rat)